Figure 3
From: A real-world study on the effectiveness of BBIBP-CorV and CoronaVac in Nanjing area
Antibody response to infection with SARS-CoV-2 of 11 CP donors. (A) Antibody production in 10 non-vaccinated CP donors; (B) Antibody levels of 1 case of CP donor vaccinated before infected with SARS-CoV-2 were compared with the average values of other non-vaccinated CP donors. Total time, the time from infection to collection; Duration, the course of disease; Vac, antibody levels of the CP donor with two doses of vaccination completed; Ave, average antibody levels of the remaining 10 non-vaccinated CP donors. Value, semi quantitative test results of antibodies (TAbs, IgG, IgA, IgM) expressed as S/CO, or quantitative test results of NAbs expressed as concentration (μg/ml). TAbs, total antibodies; NAbs, neutralizing antibodies.
